In patients with testosterone serum levels below the lower limit of the norm, the physiological levels were reached after treatment, whereas in patients with normal initial levels, the testosterone level was not significantly changed after treatment. Tribestan administered to males with idiopathic oligoasthnozoospermia or with spermogram disturbances due to varicocele, has shown increased concentration of spermatozoa, increased percentage of motile spermatozoa. Increased spermatozoa motility rate and, for some cases, increased volume of ejaculate of 1 to 2 ml. Sopharma USA Corp. All rights reserved. All other trademarks appearing on this site are trademarks or registered trademarks of their respective companies.
All trademarks are subject to the domestic laws in the respective countries.
The Tribestan trademark is subject to the pertaining international, bilateral and multilateral agreements as they may apply in various countries or is subject to common law practices as applicable in individual countries. 1998-2001 Sopharma USA Corporation . All rights reserved. A service of Bulgarian Pharmaceutical Group Ltd.